Health News Releases

  • Today February 19
December 12, 2014 15:20
MP Biomedicals Receives First Ever FDA Approval for HTLV Confirmatory Assay
MP Biomedicals, LLC, a leading provider of life science reagents, fine chemicals and diagnostic products, announced today that it has received FDA approval on the MP Diagnostics HTLV (Human T-Cell Lym
December 11, 2014 23:30
Wolters Kluwer Health Introduces UpToDate Anywhere Mobile Clinical Decision Support in Asia
Wolters Kluwer Health (http://goo.gl/o2rWK), a leading global provider of information for healthcare professionals and students, announced today the Asian launch of UpToDate® Anywhere and its first de
December 11, 2014 16:40
Nestle Skin Health to Open Global Network of Innovation Hubs to Advance Next Generation of Skin Health
Nestle Skin Health has announced plans to open a global network of ten innovation hubs around the world that will serve as a forum to develop solutions and techniques that will promote a life course o
December 10, 2014 14:35
A New Era Comes When Diabetes Can Be Treated Basically Using Cells of Pancreas
STC Stem Cell Treatment & Research Institute (www.stcstri.com) of STC Life Co., Ltd. (Chairman: Kye Ho Lee) succeeded in differentiating new pluripotent stem cells without side effect into beta-cells
December 10, 2014 11:30
Quintiles Named 2014 Frost & Sullivan Asia-Pacific CRO of the Year
For the sixth time in eight years, Quintiles (www.quintiles.com)has been named Asia-Pacific Contract Research Organization of the Year by Frost & Sullivan, a leading business research and consulting f
December 09, 2014 17:50
New data show specific antidote idarucizumab* reverses dabigatran-induced anticoagulation also in elderly and renally impaired volunteers
For Non-US/Non-UK/Non-Canadian Media New data demonstrate that a five-minute infusion of the investigational specific antidote idarucizumab led to immediate, complete and sustained reversal of the
December 09, 2014 13:55
Acelity Appoints Gaurav S. Agarwal as Group President, Businesses and Innovation
Acelity L.P. Inc. announced today the appointment of Gaurav S. Agarwal as Group President, Businesses and Innovation, a newly-created role on the Acelity senior leadership team reporting directly to J
December 09, 2014 11:20
Seattle Genetics and Takeda Report Phase 3 AETHERA Clinical Trial Data from ADCETRIS® (Brentuximab Vedotin) in Post-Transplant Hodgkin Lymphoma Patients at Risk of Relapse at ASH Annual Meeting
Seattle Genetics, Inc. (www.seattlegenetics.com) (Nasdaq: SGEN) and Takeda Pharmaceutical Company Limited (www.takeda.com) (TSE:4502) today reported data demonstrating that Hodgkin lymphoma (HL) patie
December 08, 2014 18:45
Takeda Announces Formalization of Takeda Oncology to Enhance Discovery, Development and Global Commercialization of Breakthrough Cancer Medicines
Takeda Pharmaceutical Company Limited (TSE:4502) today announced its global oncology business unit, headquartered in Cambridge, MA, will be called Takeda Oncology. The creation of Takeda Oncology will
December 08, 2014 15:20
Takeda Presents Phase 2 Data on Maintenance with Single-Agent Investigational Ixazomib in Patients with Newly Diagnosed Multiple Myeloma
Takeda Pharmaceutical Company Limited (TSE:4502) today announced results from an open-label, Phase 2 study evaluating the safety and efficacy of oral, single-agent ixazomib (MLN9708) as maintenance th
December 08, 2014 14:25
Seattle Genetics and Takeda Announce Four-Year Survival Data from ADCETRIS® (Brentuximab Vedotin) Pivotal Trial in Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma at ASH Annual Meeting
Seattle Genetics, Inc. (www.seattlegenetics.com) (Nasdaq: SGEN) and Takeda Pharmaceutical Company Limited (www.takeda.com) (TSE:4502) today announced four-year overall survival (OS) data from the ADCE
The Great Vision of a Doctor of Korean Medicine Banning Chemical Medicines
December 07, 2014 09:00
Pyunkang Korean Medicine Hospital: The Great Vision of a Doctor of Korean Medicine Banning Chemical Medicines
What is the limit of the human lifespan? Biologists consider the age of about 120 years to be the limit of the human lifespan on the premises that the majority of animals live up to 6 times the period
December 05, 2014 16:40
Otsuka Pharmaceutical to Acquire Avanir Pharmaceuticals
Otsuka Pharmaceutical Co., Ltd. is pleased to announce an agreement with Avanir Pharmaceuticals, Inc. (“Avanir”) in which Otsuka America, Inc., a US subsidiary, acquires Avanir for USD 3.5 billion in
December 05, 2014 14:25
Quintiles Named Best Contract Research Organization at SCRIP Awards for Third Consecutive Year
Quintiles today announced that the company was awarded “Best Contract Research Organization (http://goo.gl/UnKZEb)” at the annual SCRIP Awards for the third year in-a-row. This is the company’s fourth
December 04, 2014 23:30
St. Luke’s Medical Center-Global City Trusts UpToDate to Support Exceptional Standards of Care
Wolters Kluwer Health (http://goo.gl/o2rWK), a leading global provider of information for healthcare professionals and students, announced today that St. Luke’s Medical Center-Global City is among the
December 02, 2014 16:40
Quintiles Launches Marketed Product Maintenance Offering to Better Manage Established Products
Quintiles today announced a new offering that combines its industry-leading pharmacovigilance, regulatory dossier/label maintenance, benefit-risk management, and analytic expertise into one integrated
December 02, 2014 15:50
Takeda’s Investigational, Oral Proteasome Inhibitor Ixazomib Granted Breakthrough Therapy Designation by U.S. FDA for Relapsed or Refractory Systemic Light-chain Amyloidosis
Takeda Pharmaceutical Company Limited (TSE:4502) today announced that the U.S. Food & Drug Administration (FDA) has granted Breakthrough Therapy status to the company’s investigational, oral proteasom
December 01, 2014 16:30
AHF Global World AIDS Day Events Focus On Testing and Treatment
PHOTO: For World AIDS Day, AHF will host over 160 events around the world to promote testing, treatment for HIV/AIDS; international commemorations will launch global campaign to connect twenty million
November 28, 2014 23:00
PENTAX Medical Launches New ENT Videoscope Solution
PENTAX Medical launches today the new VIVIDEO system, an advanced ENT videoscope solution, in the European, Middle Eastern and African (EMEA) Markets. This endoscopy system consists of a video process
November 27, 2014 17:50
Vargatef® (nintedanib*) approved in the EU for lung cancer patients with advanced adenocarcinoma after first-line chemotherapy
For media outside UK, US and Canada only Today Boehringer Ingelheim announced that the European Commission has granted EU marketing authorisation for Vargatef® (nintedanib*), valid for the 28 count
November 24, 2014 16:10
Nintedanib* receives positive CHMP opinion in European Union for the treatment of IPF
For media outside UK, US and Canada Boehringer Ingelheim today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive
November 24, 2014 15:10
Cell Signaling Technology Wins “Best Antibodies” and “Most Useful Website” at The Life Science Industry Awards
Cell Signaling Technology, a leading provider of antibodies, kits and services, announced today that it has won two Life Science Industry Awards® for “Best Antibodies” and “Most Useful Website.” Hoste
November 20, 2014 17:50
Panasonic Showcases Advanced Hospital Solutions at HOSPEX Japan 2014
Panasonic exhibited a variety of advanced equipment and solutions for medical and welfare facilities at the 39th International Healthcare Engineering Exhibition (HOSPEX Japan 2014) held on November 12
November 20, 2014 13:05
Terumo BCT and Banco de Sangre de Servicios Mutuos Unite in a Treatment Use Program Developed to Help Improve Blood Supply Safety Using an Investigational Device
Due to public health concerns over the transmission of chikungunya virus (CHIKV) and dengue fever, Terumo BCT will file a submission to the U.S. Food and Drug Administration (FDA) for expanded access
November 20, 2014 13:00
ADDING MULTIMEDIA Quintiles Named a Best Workplace in South Korea
Quintiles (www.quintiles.com) announced today that it has been recognized as one of South Korea’s Best Workplaces by the Great Place to Work® Institute. This is Quintiles Korea’s first time to receive
25 per page50 per page75 per page100 per page